Pharmafile Logo

Moving Beyond the Pill: Unlocking Value Through Engaged, Empowered, and Educated Patients

True “beyond-the-pill” strategy requires shifting from a prescriptive model to a supportive one—using personalized digital tools and authentic patient voices to drive adherence, improve outcomes, and prove value.

- PMLiVE

The healthcare ecosystem is undergoing a fundamental, albeit gradual and sometimes painfully slow, transformation, shifting from a volume-based model—where prescription volume is prioritized—to one driven by value-based care. In this beyond-the-pill model, emphasis is placed not only on clinical outcomes, but also on real-world patient experiences. At a time when patients demand greater transparency and control over their health journey, patient engagement is no longer a nice-to-have feature or a regulatory checkmark for Pharma—it is a measurable driver of long-term commercial sustainability.

The efficacy of even the most innovative therapies can be fundamentally eroded by poor adherence, low health literacy, and disconnected care pathways. To overcome these issues, creating an environment where the patient is recognized as an active participant in their care journey, empowered to understand and manage their condition, is critical.

Key Elements to Ensure Activated and Involved Patients

1. Shared Decision-making

A female doctor in a white lab coat is showing her patient something on a tablet - engaging in shared decision-making to make the patient feel more empowered.

First and foremost, improved patient activation requires shared decision-making (SDM). SDM can be defined as a collaborative process that merges clinical evidence with the patient’s values, preferences, and lifestyle to select the optimal treatment path. For Pharma, this represents a crucial strategic shift: moving away from a prescriptive model (Pharma → Prescriber → Patient) to a supportive model that enhances HCP-patient dialogue.

This supportive approach can take many shapes, but one of the most straightforward involves developing tools and resources that enable open, balanced HCP-patient conversations. There is no limit to what this can look like, but popular examples include interactive symptom trackers, risk/benefit calculators, eDiaries, and easy-to-use digital decision aids that direct patients to pertinent information based on their individual demographic and clinical characteristics or risk factors, along with printed and digital educational materials covering the topics that matter most to patients. By investing in SDM support tools, Pharma can help ensure patients not only start therapy but also align psychologically with it, setting the foundation for long-term adherence and treatment success.

2. Personalization

The second key factor is radical personalization. Moving beyond basic patient segmentation, true personalization means addressing the patient’s unique and complex barriers and needs. This includes social determinants of health (SDoH), health literacy gaps, logistical hurdles, and/or underlying emotional states…

Read the full article

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Top 10 Tips for “Virtualizing” In-person Meetings

With over 11 years of experience in virtualizing meetings in the life science industry, Impetus Digital has a wealth of experience and knowledge to share.

Using Health IT to Improve the Healthcare System

Scott Arrol, Chief Executive Officer at New Zealand Health IT, discusses the roles of interoperability, connected health, and digital identity in enabling a healthier population. We also explore how NZHIT and…

Unleashing the Potential of Multichannel Digital Strategies in Healthcare

Christine Jacob, Founder and Managing Director of Digi-Bridges, talks about the future of mobile and digital health, including exciting technologies such as VR and AR. We also touch on a wide variety…

Virtual Hackathon on Healthcare Innovation: a Customer Story

How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual “hackathon,” with spectacular results.

Artificial Intelligence in Digital Therapeutics

Leo Grady, CEO of Paige.AI uncovers what it has been like being a pioneer in the digital therapeutic space and the many challenges that come with bringing AI technology to market….

Virtual Reality in Medicine and Clinical Research

In the latest episode of Impetus Digital’s Fireside Chat, I sit down with Ville Leppälä, Vertical Lead, Research and Medical, at Varjo. We discuss the potential applications of virtual reality, augmented…

Potential Benefits and Dangers of Big Data Analytics

In this episode of Impetus Digital’s Fireside Chat, I sit down with Brenda McPhail from the Canadian Civil Liberties Association. We talk about a myriad of different subjects related to…

VR/AR Applications for Training and Healthcare

In the latest episode of Impetus Digital’s Fireside Chat, I sit down with Mike Waldron, who is the CEO and Co-Founder of Propel VR. We discuss how virtual reality (VR)…

Changing and Sustaining Lifestyle Habits with Digital Therapeutics

In this fireside chat, Natalie Yeadon sat down with Jeffrey Ruby, Founder & CEO of Newtopia and discussed how a combination of genetic testing, personality-matched coaching, and smart technology can…

Secondary effects of COVID-19 on the healthcare system and patients

We are getting to the point where we need to start considering the long-term effects on the healthcare system when making decisions.